Aetna (AET) Price Target Raised to $208.00 at Credit Suisse Group

Aetna (NYSE:AET) had its price objective hoisted by Credit Suisse Group from $200.00 to $208.00 in a research note issued to investors on Wednesday. The brokerage currently has a “neutral” rating on the stock. Credit Suisse Group’s target price points to a potential upside of 11.34% from the company’s previous close.

Several other research analysts have also recently weighed in on AET. Citigroup cut Aetna from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $187.89 to $212.00 in a research report on Wednesday. Piper Jaffray Companies reissued a “buy” rating and issued a $212.00 price objective on shares of Aetna in a research report on Tuesday. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Cowen reissued a “buy” rating and issued a $212.00 price objective on shares of Aetna in a research report on Tuesday. Finally, Deutsche Bank raised Aetna from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $195.00 to $212.00 in a research report on Monday, January 22nd. Eleven research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $185.94.

Shares of Aetna (NYSE:AET) traded down $1.07 during trading hours on Wednesday, hitting $186.82. The company had a trading volume of 3,425,768 shares, compared to its average volume of 2,670,000. The stock has a market capitalization of $60,920.00, a PE ratio of 32.49, a price-to-earnings-growth ratio of 1.64 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. Aetna has a one year low of $116.37 and a one year high of $194.40.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.18 by $0.07. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. During the same quarter in the previous year, the firm earned $0.08 earnings per share. The business’s revenue was down 6.2% on a year-over-year basis. analysts anticipate that Aetna will post 9.78 earnings per share for the current year.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Opera Trading Capital purchased a new position in shares of Aetna during the 4th quarter valued at $1,060,000. Mutual of America Capital Management LLC lifted its position in shares of Aetna by 25.9% during the 4th quarter. Mutual of America Capital Management LLC now owns 71,318 shares of the company’s stock valued at $12,865,000 after buying an additional 14,687 shares during the last quarter. Dupont Capital Management Corp lifted its position in shares of Aetna by 1,457.2% during the 4th quarter. Dupont Capital Management Corp now owns 24,838 shares of the company’s stock valued at $4,481,000 after buying an additional 23,243 shares during the last quarter. SignalPoint Asset Management LLC purchased a new position in shares of Aetna during the 4th quarter valued at $216,000. Finally, Bessemer Group Inc. lifted its position in shares of Aetna by 19.8% during the 4th quarter. Bessemer Group Inc. now owns 13,363 shares of the company’s stock valued at $2,410,000 after buying an additional 2,205 shares during the last quarter. 87.85% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Aetna (AET) Price Target Raised to $208.00 at Credit Suisse Group” was originally posted by American Banking and Market News and is the property of of American Banking and Market News. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/31/aetna-aet-price-target-raised-to-208-00-at-credit-suisse-group.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)